| Clinical data | |
|---|---|
| Pronunciation | /loʊˈpɛrəmaɪd/ |
| Trade names | Imodium, others |
| Other names | R-18553, Loperamide hydrochloride (USAN US) |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682280 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | <1% |
| Protein binding | ~95-97% |
| Metabolism | Liver (extensive) |
| Metabolites | N-Desmethyloperamide, Loperamide-N-oxide, Loperamide carbinolamide metabolite |
| Onset of action | ~1 hour |
| Elimination half-life | 9–14 hours |
| Duration of action | Up to 3 days |
| Excretion | Feces (30–40%), urine (1%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.088 |
| Chemical and physical data | |
| Formula | C29H33ClN2O2 |
| Molar mass | 477.05 g·mol−1 |
| 3D model (JSmol) | |
| Solubility in water | The water solubility of loperamide is approximately 0.14 g/100 mL at room temperature.CID Loperamide from PubChem |
| |
| |
Loperamide hydrochloride (Brand nameː Imodium) is a man-made (synthetic) drug that treats diarrhoea and irritable bowel syndrome (IBS). It is taken orally, as tablets or capsules, liquid suspension (1mg/7.5mL) and also comes in formations that melt on the tongue. The tablets are 2mg each. It is available OTC (over the counter) in most countries including the UK and USA.
The drug is taken to treat diarrhoea short-term but can be used long-term to treat symptoms of some bowel conditions, in Crohn's disease, ulcerative colitis, and short bowel syndrome, for example. It is also given to patients after some types of surgery, for example it is used in high doses after a colonoscopy to make the bowel movements (poo) less runny. Imodium is also indicated for treating high amounts of fecal discharge in ileostomies. It reduces symptoms normally around 1 hour after taking it.
Loperamide does not treat underlying causes. This means it only treats symptoms, but does not make what is causing diarrhoea go away, if there is an underlying cause. There may be side-effects from the underlying cause not related to the medicine, but using loperamide can causeː
When it is used with children, the drug has many different effects, or a high range of results or side effects, and is not safe to use in children. People with AIDS treated with loperamide for diarrhea may see abdominal distension and should stop therapy if this happens.
Serious side effects from loperamide are rare. If there is an allergic reaction to the drug there may be swelling, redness, gasping for air (or trouble breathing), skin turning grey, blue or purple, dizziness, drowsiness, clamminess, confusion or fainting, can be an allergic or adverse reaction. If this happens it is a medical emergency, like other serious side effects.
There may be other side effects of the drug or brand, which should be listed on the leaflet inside the packet. Other, non-allergic serious side effects include
The IUPAC name for loperamide is 4-(p-chlorophenyl)-4-hydroxy-N, N-dimethyla, a-diphenyl-1-piperidinebutyramide, and can be attached to a monohydrochloride (one hydro-chloride) salt or base.
Loperamide can be sold as a combination medication, under the brand name simeticone, to treat flatulence (farting). When it is in this form it is combined with a soap to treat two symptoms at once. As simethicone its structure has a silicon dioxide attached, which is not physiologically active.